Enhanced BLI analytics accelerate your drug research, development, and manufacturing

Introducing the new Octet^® R8e BLI System, the latest and most advanced biolayer interferometry (BLI) system for label-free, real-time biomolecular interaction analysis. In this interview, Deirdre Raduns, Octet^® Product Manager at Sartorius, shares how enhanced BLI analytics achieve new heights of sensitivity, empowering users with exceptional sensitivity, extended run times, flexible assay design, and seamless compliance with 21 CFR Part 11. Discover how Octet^® BLI boosts flexibility, throughput, and automation to streamline complex workflows in drug discovery, process development, and quality control under GxP regulations.

This video was filmed at SLAS Europe 2025.